Results 111 to 120 of about 120,496 (233)

Challenging Medical and Surgical Management of Ectopic Parathyroid Hormone (PTH) Adenomas in the Elderly. [PDF]

Cureus
Karaca A, Demirel K, Mahamud B, Hussein F, Mlawa G.   +4 more
europepmc   +1 more source

Variations in Serum Albumin Levels Over Time in Patients Treated With Conventional Hemodialysis or Expanded Hemodialysis: A Cohort Study

Hemodialysis International, EarlyView.
ABSTRACT Introduction Hypoalbuminemia is a well‐established risk factor for mortality in chronic hemodialysis (HD) patients. To evaluate the association of time‐varying serum albumin with the type of dialyzer, we analyzed serum albumin over time in two cohorts of HD patients, one receiving HDx therapy enabled by the Theranova dialyzer and the other ...
Juan C. Castillo, Jasmin Vesga, Angela Rivera, Peter Rutherford, Ricardo Sanchez, Henry Oliveros, Bengt Lindholm, Mauricio Sanabria, on behalf of the Colombian Registry of Expanded Hemodialysis Investigators   +8 more
wiley   +1 more source

Effectiveness of Bilateral Internal Jugular Parathyroid Hormone Measurements in Optimizing Hyperparathyroidism Surgery Outcomes. [PDF]

OTO Open
Ribeiro DK, das Neves MC, Santos RO, Ohe MN, Lazaretti-Castro M, Rosano M, Abrahao M.   +6 more
europepmc   +1 more source

Cardiovascular Biomarkers in Nocturnal Hemodialysis and Their Association With Physical Performance

Hemodialysis International, EarlyView.
ABSTRACT Introduction The cardiovascular biomarkers troponin T, N‐terminal pro‐B‐type natriuretic peptide, and fibroblast growth factor 23 are elevated in hemodialysis patients and associated with an increased cardiovascular mortality risk. Nocturnal hemodialysis improves the fluid status in hemodialysis patients.
Manouk Dam, Laura M. M. de Haan, Tiny Hoekstra, Marc Vervloet, Frans J. van Ittersum, Peter J. M. Weijs, Brigit C. van Jaarsveld   +6 more
wiley   +1 more source

Treatment of postmenopausal osteoporosis with recombinant human parathyroid hormone and electromagnetic field. [PDF]

Aging Clin Exp Res
Xuan M, Wang B, Bi W, Li Y, Song L, Xie Z, Liu Q, Zhang X.   +7 more
europepmc   +1 more source

Bioassay of Parathyroid Hormone.

Experimental Biology and Medicine, 1953
Ralph I. Dorfman, Betty L. Rubin
openaire   +3 more sources

First‐line treatment of osteoporosis with osteoanabolic therapy: a new opportunity

Internal Medicine Journal, EarlyView.
Abstract Osteoporosis is a national health priority, and over six million Australians over the age of 50 years have poor bone health. Fragility fractures due to osteoporosis are associated with an increased morbidity and mortality risk and a high economic cost to the community. It is a chronic condition requiring long‐term management.
Jasna Aleksova, Peter Ebeling
wiley   +1 more source

CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro. [PDF]

Bone Joint Res
Larraz-Prieto B, Lind LH, Olesen JB, Azfer A, Hansen MS, Frost M, Jafari A, Ralston SH, Søe K, Alonso N.   +9 more
europepmc   +1 more source

Tests on Three Antisera und Subsequent Development of Radioimmunoassay for Different Regions of Human parathyrin [PDF]

, 1979
Marschner, I., Scriba, Peter Christian, Wood, W. G.   +2 more
core  

The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Journal of Neuroendocrinology, EarlyView.
Abstract The biology of metastatic pancreatic neuroendocrine tumors (panNET) may alter over time. It remains to be defined if, how, and when this patient group should be recommended to re‐evaluate the characteristics of their disease. This prospective single‐center, longitudinal cohort study at Uppsala University Hospital, Sweden (NCT03130205 ...
Kazhan Mollazadegan, Johan Botling, Britt Skogseid, Barbro Eriksson, Lovisa Falkman, Liang Zhang, Ieva Lase, Staffan Welin, Anders Sundin, Joakim Crona   +9 more
wiley   +1 more source